Stage IIIC Lung Cancer AJCC v8 (DBCOND0111248)

Identifiers

Synonyms
Not Available

Associated Data

Indicated Drugs and Targets
Not Available
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT04785287
Anti-CTLA4-NF mAb (BMS986218), Nivolumab, and Stereotactic Body Radiation Therapy for the Treatment of Metastatic Solid Malignanciestreatment1 / 2active_not_recruiting
NCT04892953
Local Consolidative Therapy and Durvalumab for Oligoprogressive and Polyprogressive Stage III NSCLC After Chemoradiation and Anti-PD-L1 Therapytreatment2recruiting
NCT04751747
Adaptive Radiation Planning for the Reduction of Radiation-Induced Toxicity in Patients With Stage II-IV Non-small Cell Lung CancerNo drug interventionssupportive_careNot Availablerecruiting
NCT04073745
Single Fraction Stereotactic Body Radiation Therapy After Surgery in Treating Patients With Non-small Cell Lung CancerNo drug interventionstreatment1recruiting
NCT04227028
Brigatinib and Bevacizumab for the Treatment of ALK-Rearranged Locally Advanced, Metastatic, or Recurrent NSCLCtreatment1active_not_recruiting
NCT04186988
[18F]-AraG for the Detection of T-Cell Activation in Advanced Non-small Cell Lung Cancer Patients Undergoing PD-1/PD-L1-Directed TherapyNo drug interventionsdiagnostic0withdrawn
NCT04701307
Niraparib and Dostarlimab for the Treatment of Small Cell Lung Cancer and Other High-Grade Neuroendocrine Carcinomastreatment2active_not_recruiting
NCT05340309
Subcutaneous Atezolizumab for the Treatment of Non-small Cell Lung Cancertreatment2recruiting
NCT04940299
Tocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial Carcinomatreatment2active_not_recruiting
NCT03830918
Niraparib, Temozolomide and Atezolizumab in Treating Patients With Advanced Solid Tumors and Extensive-Stage Small Cell Lung Cancer With a Complete or Partial Response to Platinum-Based First-Line Chemotherapytreatment1 / 2recruiting
NCT04183218
Characterizing Chemo-Radiotherapy Treatment-Related Cardiac ChangesNo drug interventionsNot AvailableNot Availablecompleted
NCT04929041
Testing the Addition of Radiation Therapy to Immunotherapy for Stage IV Non-Small Cell Lung Cancer Patients Who Are PD-L1 Negativetreatment2 / 3recruiting
NCT03637816
Anamorelin Hydrochloride in Reducing Anorexia in Patients With Advanced Non-small Cell Lung Cancersupportive_care2 / 3active_not_recruiting
NCT03867916
Patient Portal and Navigation Program in Providing Information for Asian American Cancer PatientsNo drug interventionshealth_services_researchNot Availablecompleted
NCT05166616
Minnelide and Osimertinib for the Treatment of Advanced EGFR Mutated Non-Small Cell Lung Cancertreatment1recruiting
NCT04396535
Docetaxel With or Without Bintrafusp Alfa for the Treatment of Advanced Non-small Cell Lung Cancertreatment2terminated
NCT05096663
Testing the Use of Combination Immunotherapy Treatment (N-803 [ALT-803] Plus Pembrolizumab) Against the Usual Treatment for Advanced Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)treatment2 / 3active_not_recruiting
NCT04705025
Cognitive-Behavioral Stress Management Device for the Treatment of Anxiety and Depressive Symptoms in Patients With Stage I-III Breast or Lung CancerNo drug interventionssupportive_careNot Availableterminated
NCT05570825
SX-682 With Pembrolizumab for the Treatment of Metastatic or Recurrent Stage IIIC or IV Non-Small Cell Lung Cancertreatment2recruiting
NCT04771520
Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Solid Tumorstreatment2recruiting
NCT04372927
ADMIRAL Trial: Adaptive Mediastinal Radiation With Chemo-Immunotherapytreatment2terminated
NCT05022394
Sapanisertib and Nivolumab for the Treatment of Stage I-IV Non-small Cell Lung Cancer in Patients Who Have Progressed on Prior PD-1/PD-L1 Inhibitor Therapy, I-OVERCOME Studytreatment1 / 2withdrawn
NCT04902040
Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodiestreatment1 / 2recruiting
NCT04505267
NBTXR3 and Radiation Therapy for the Treatment of Inoperable Recurrent Non-small Cell Lung CancerNo drug interventionstreatment1recruiting
NCT03995667
Tumor Treating Fields (TTFields) Therapy to Manage Brain Metastases in Small Cell Lung CancerNo drug interventionsprevention2terminated
NCT05136846
Papaverine in Combination With Chemoradiation for the Treatment of Stage II-III Non-small Cell Lung Cancertreatment1recruiting
NCT05269381
Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumorstreatment1 / 2recruiting
NCT04789681
Canakinumab for the Prevention of Lung Cancer, the Can-Prevent-Lung Trialprevention2recruiting
NCT02419495
Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced Malignanciestreatment1active_not_recruiting
NCT03735095
Endobronchial Ultrasound Guided Interstitial Photodynamic Therapy in Treating Patients With Locally Advanced Lung Cancertreatment1 / 2active_not_recruiting
NCT05407038
Remote Monitoring With Health-Coaching for Lifestyle Changes in Patients With Lung Cancer Related FatigueNo drug interventionssupportive_careNot Availableactive_not_recruiting
NCT02955290
CIMAvax Vaccine, Nivolumab, and Pembrolizumab in Treating Patients With Advanced Non-small Cell Lung Cancer or Squamous Head and Neck Cancertreatment1 / 2recruiting
NCT03225664
Trametinib and Pembrolizumab in Treating Patients With Recurrent Non-small Cell Lung Cancer That Is Metastatic, Unresectable, or Locally Advancedtreatment1 / 2active_not_recruiting
NCT04971187
Bintrafusp Alfa With Chemotherapy for Tyrosine Kinase Inhibitor-Resistant EGFR-Mutant Non-small Cell Lung Cancertreatment2terminated
NCT03590054
Abexinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumor Malignanciestreatment1completed
NCT03776253
Conquer Fear SUPPORT Intervention in Supporting Patients With Stage III-IV Lung or Gynecologic CancerNo drug interventionssupportive_careNot Availableactive_not_recruiting
NCT04662645
Embedded Palliative Care in Managing Symptoms in Participants With Recurrent Stage III-IV Thoracic Malignancies and Their CaregiversNo drug interventionssupportive_careNot Availablecompleted
NCT04428905
Self-Management Survivorship Care in Stage I-III Non-small Cell Lung Cancer or Colorectal CancerNo drug interventionssupportive_careNot Availableactive_not_recruiting
NCT04819997
A Nurse-Led Intervention for Fear of Progression in Advanced CancerNo drug interventionssupportive_careNot Availableactive_not_recruiting
NCT04092283
Testing the Addition of an Antibody to Standard Chemoradiation Followed by the Antibody for One Year to Standard Chemoradiation Followed by One Year of the Antibody in Patients With Unresectable Stage III Non-Small Cell Lung Cancertreatment3active_not_recruiting
NCT02983578
Danvatirsen and Durvalumab in Treating Patients With Advanced and Refractory Pancreatic, Non-Small Cell Lung Cancer, and Mismatch Repair Deficient Colorectal Cancertreatment2active_not_recruiting
NCT05213078
Family Caregivers in Underserved Populations Providing Complex Cancer CareNo drug interventionssupportive_careNot Availablecompleted
NCT05010109
Cardiovascular Injury and Cardiac Fitness in Locally Advanced Non-Small Cell Lung Cancer Patients Receiving Model Based Personalized ChemoradiationNo drug interventionsdiagnostic1recruiting
NCT03731585
Online Psychosocial Intervention in Improving Social Well-Being and Support in Women With Stage I-IV Non-small Cell Lung Cancer Undergoing TreatmentNo drug interventionssupportive_careNot Availableactive_not_recruiting
NCT03948100
Dyadic Yoga Intervention in Improving Physical Performance and Quality of Life in Patients With Stage I-IV Non-small Cell Lung or Esophageal Cancer Undergoing Radiotherapy and Their CaregiversNo drug interventionssupportive_careNot Availablerecruiting
NCT05412875
Pilot Trial of E Cigarettes in Pts Diagnosed With Cancer of the Head, Neck, and Lungsupportive_careNot Availablewithdrawn
NCT04013542
Ipilimumab and Nivolumab in Combination With Radiation Therapy in Treating Patients With Stage 2-3 Non-small Lung Cancertreatment1active_not_recruiting
NCT04837716
Ensartinib, Carboplatin, Pemetrexed and Bevacizumab for the Treatment of Stage IIIC or IV or Recurrent ALK-Positive Non-small Cell Lung Cancertreatment1active_not_recruiting
NCT03819296
Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancertreatment1 / 2recruiting
NCT03902535
Geriatric and Quality of Life Assessments in Older Patients With Non-metastatic or Metastatic Head and Neck or Lung Cancer Undergoing Surgery or Chemoradiation and Their CaregiversNo drug interventionsNot AvailableNot Availablecompleted
NCT04430725
Microwave Ablation or Wedge Resection for the Treatment of Lung, Sarcoma and Colorectal Lesions, ALLUME StudyNo drug interventionsNot AvailableNot Availablerecruiting
NCT05017025
Aurora Kinase Inhibitor LY3295668 in Combination With Osimertinib for the Treatment of Advanced or Metastatic EGFR-Mutant Non-squamous Non-small Cell Lung Cancertreatment1 / 2active_not_recruiting
NCT03707574
Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot StudyNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT05334329
Genetically Engineered Natural Killer (NK) Cells With or Without Atezolizumab for the Treatment of Non-small Cell Lung Cancer Previously Treated With PD-1 and/or PD-L1 Immune Checkpoint Inhibitorstreatment1active_not_recruiting
NCT06096844
Chemotherapy Combined With Immunotherapy vs Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trialtreatment3recruiting
NCT03939481
Treatment Effects on Development of Chemotherapy-Induced Peripheral Neuropathy in Patients With CancerNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT03793179
Testing the Timing of Pembrolizumab Alone or With Chemotherapy as First Line Treatment and Maintenance in Non-small Cell Lung Cancertreatment3active_not_recruiting